N. Martel

1.0k total citations
30 papers, 838 citations indexed

About

N. Martel is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, N. Martel has authored 30 papers receiving a total of 838 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in N. Martel's work include Cancer-related Molecular Pathways (7 papers), Pregnancy and preeclampsia studies (2 papers) and Chemical Synthesis and Analysis (2 papers). N. Martel is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Pregnancy and preeclampsia studies (2 papers) and Chemical Synthesis and Analysis (2 papers). N. Martel collaborates with scholars based in France, Germany and Japan. N. Martel's co-authors include Hiroshi Yamasaki, Hisayoshi Nakazawa, Hiroshi Yamasaki, Bruce K. Armstrong, Dallas R. English, K. Nakazawa, Peter L. Randell, Taira Enomoto, Yoshinobu Kanno and Monica Hollstein and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

N. Martel

30 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Martel France 15 505 227 144 97 96 30 838
Silvia Demontis Italy 10 417 0.8× 131 0.6× 74 0.5× 67 0.7× 25 0.3× 10 584
H U Kontny United States 9 768 1.5× 429 1.9× 172 1.2× 32 0.3× 28 0.3× 10 1.1k
Irit Zurer Israel 10 590 1.2× 357 1.6× 228 1.6× 150 1.5× 17 0.2× 11 951
Katherine Drews‐Elger United States 13 514 1.0× 359 1.6× 235 1.6× 80 0.8× 41 0.4× 20 1.0k
Joanne S. Finch United States 17 563 1.1× 286 1.3× 303 2.1× 18 0.2× 48 0.5× 24 912
Junichi Furuta Japan 16 503 1.0× 144 0.6× 137 1.0× 57 0.6× 232 2.4× 43 909
Lavinia Nardinocchi Italy 16 702 1.4× 549 2.4× 365 2.5× 56 0.6× 26 0.3× 20 1.1k
Masamichi Inami Japan 17 331 0.7× 173 0.8× 57 0.4× 218 2.2× 24 0.3× 41 1.0k
Kerstin Müller Germany 15 237 0.5× 115 0.5× 100 0.7× 50 0.5× 57 0.6× 25 717
W K Hong United States 14 745 1.5× 285 1.3× 199 1.4× 85 0.9× 35 0.4× 18 1.2k

Countries citing papers authored by N. Martel

Since Specialization
Citations

This map shows the geographic impact of N. Martel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Martel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Martel more than expected).

Fields of papers citing papers by N. Martel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Martel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Martel. The network helps show where N. Martel may publish in the future.

Co-authorship network of co-authors of N. Martel

This figure shows the co-authorship network connecting the top 25 collaborators of N. Martel. A scholar is included among the top collaborators of N. Martel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Martel. N. Martel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kallassy, Mireille, N. Martel, Odile Damour, Hiroshi Yamasaki, & Hisayoshi Nakazawa. (1998). Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21WAF1 gene expression. Molecular Carcinogenesis. 21(1). 26–36. 2 indexed citations
2.
Saito, Tsuyoshi, Achim Schneider, N. Martel, et al.. (1997). Proliferation-Associated Regulation of Telomerase Activity in Human Endometrium and Its Potential Implication in Early Cancer Diagnosis. Biochemical and Biophysical Research Communications. 231(3). 610–614. 66 indexed citations
3.
Fusco, Alfredo, et al.. (1993). Possible role of activated ras genes in human esophageal carcinogenesis. International Journal of Cancer. 54(6). 978–982. 10 indexed citations
4.
Loktionov, Alexandre, Irina G. Popovich, Mark A. Zabezhinski, et al.. (1992). Transplacental and transgeneration carcinogenic effect of 7,12-dimethylbenz[a]anthracene: relationship with ras oncogene activation. Carcinogenesis. 13(1). 19–24. 18 indexed citations
5.
Loktionov, Alexandre, Monica Hollstein, N. Martel, et al.. (1990). Tissue‐specific activating mutations of Ha‐ and Ki‐ras oncogenes in skin, lung, and liver tumors induced in mice following transplacental exposure to DMBA. Molecular Carcinogenesis. 3(3). 134–140. 40 indexed citations
6.
Yamasaki, Hiroshi, Monica Hollstein, N. Martel, et al.. (1987). Transplacental induction of a specific mutation in fetal Ha‐ras and its critical role in post‐natal carcinogenesis. International Journal of Cancer. 40(6). 818–822. 27 indexed citations
7.
Yamasaki, Hiroshi, et al.. (1987). Selective lack of intercellular communication between transformed and nontransformed cells as a common property of chemical and oncogene transformation of BALB/c 3T3 cells.. PubMed. 47(21). 5658–64. 88 indexed citations
8.
Ljubimov, Alexander V., N. Martel, & Hideo Yamasaki. (1985). Response of cultured rat liver epithelial cell lines to tumour-promoting phorbol esters. Experimental Cell Research. 156(2). 311–324. 7 indexed citations
9.
Enomoto, Taira, N. Martel, Yoshinobu Kanno, & Hiroshi Yamasaki. (1984). Inhibition of cell communication between Balb/c 3t3 cells by tumor promoters and protection by cAMP. Journal of Cellular Physiology. 121(2). 323–333. 83 indexed citations
10.
Martel, N., et al.. (1984). Characterization of a human placental factor which inhibits specific binding of phorbol esters to cultured cells. Carcinogenesis. 5(1). 15–21. 7 indexed citations
11.
Drevon, C., et al.. (1982). In vitro studies on the mechanism of tumor promoter-mediated inhibition of cell differentiation.. PubMed. 7. 359–77. 3 indexed citations
12.
Yamasaki, Hiroshi, C. Drevon, & N. Martel. (1982). Specific binding of phorbol esters to Friend erythroleukemia cells — general properties, down regulation and relationship to cell differentiation. Carcinogenesis. 3(8). 905–910. 22 indexed citations
13.
Yamasaki, Hiroshi & N. Martel. (1981). Inhibitory effect of tumor promoting phorbol esters and mezerein on human mixed lymphocyte reaction. Cancer Letters. 12(1-2). 43–52. 9 indexed citations
14.
Yamasaki, Hiroshi, et al.. (1980). Long-term effect of a tumor promoter, 12-O-tetradecanoylphorbol-13-acetate, on induced differentiation of Friend leukemia cells.. PubMed. 40(10). 3780–5. 9 indexed citations
15.
Martel, N., et al.. (1979). Differences in the slopes of dose-response curves measuring pregnancy specific β1-glycoprotein (SP1) by means of radioimmunoassay. Clinica Chimica Acta. 95(2). 347–351. 10 indexed citations
16.
Sizaret, P, et al.. (1978). Interactions of Alpha‐fetoprotein and Other Proteins with Concanavalin A. Scandinavian Journal of Immunology. 8(s8). 319–322. 5 indexed citations
17.
Muenz, Larry R., C. Bernard, J.A. Chayvialle, et al.. (1978). Results of the second international study on the W.H.O. alpha-foetoprotein standard. Journal of Biological Standardization. 6(3). 187–199. 2 indexed citations
18.
Sizaret, P, N. Martel, A Tuyns, & Stéphanie Reynaud. (1977). Mean α-Fetoprotein Values of 1,333 Males over 15 Years by Age Groups. Digestion. 15(2). 97–103. 14 indexed citations
19.
20.
Tuyns, A, et al.. (1975). α‐FETOPROTEIN LEVELS IN NORMAL MALES FROM SEVEN ETHNIC GROUPS WITH DIFFERENT HEPATOCELLULAR CARCINOMA RISKS. Annals of the New York Academy of Sciences. 259(1). 136–155. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Demontis Breakdown of academic impact, for papers by H U Kontny Breakdown of academic impact, for papers by Irit Zurer Breakdown of academic impact, for papers by Katherine Drews‐Elger Breakdown of academic impact, for papers by Joanne S. Finch Breakdown of academic impact, for papers by Junichi Furuta Breakdown of academic impact, for papers by Lavinia Nardinocchi Breakdown of academic impact, for papers by Masamichi Inami Breakdown of academic impact, for papers by Kerstin Müller Breakdown of academic impact, for papers by W K Hong
Rankless by CCL
2026